These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 35360245)

  • 1. Potential Role of Chronic Physical Exercise as a Treatment in the Development of Vitiligo.
    de França E; Dos Santos RVT; Baptista LC; Da Silva MAR; Fukushima AR; Hirota VB; Martins RA; Caperuto EC
    Front Physiol; 2022; 13():843784. PubMed ID: 35360245
    [No Abstract]   [Full Text] [Related]  

  • 2. New insights into immune mechanisms of vitiligo.
    Boniface K; Taïeb A; Seneschal J
    G Ital Dermatol Venereol; 2016 Feb; 151(1):44-54. PubMed ID: 26512930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and cellular basis of depigmentation in vitiligo patients.
    Delmas V; Larue L
    Exp Dermatol; 2019 Jun; 28(6):662-666. PubMed ID: 30536790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review.
    Białczyk A; Wełniak A; Kamińska B; Czajkowski R
    Mol Diagn Ther; 2023 Nov; 27(6):723-739. PubMed ID: 37737953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Promising Role of Chemokines in Vitiligo: From Oxidative Stress to the Autoimmune Response.
    He S; Xu J; Wu J
    Oxid Med Cell Longev; 2022; 2022():8796735. PubMed ID: 35096274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
    Boniface K; Seneschal J; Picardo M; Taïeb A
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):52-67. PubMed ID: 28685247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitiligo: pathogenetic hypotheses and targets for current therapies.
    Guerra L; Dellambra E; Brescia S; Raskovic D
    Curr Drug Metab; 2010 Jun; 11(5):451-67. PubMed ID: 20540698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8.
    Toosi S; Orlow SJ; Manga P
    J Invest Dermatol; 2012 Nov; 132(11):2601-9. PubMed ID: 22696056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitexin protects melanocytes from oxidative stress via activating MAPK-Nrf2/ARE pathway.
    Li XS; Tang XY; Su W; Li X
    Immunopharmacol Immunotoxicol; 2020 Dec; 42(6):594-603. PubMed ID: 33045867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The enigma and challenges of vitiligo pathophysiology and treatment.
    Abdel-Malek ZA; Jordan C; Ho T; Upadhyay PR; Fleischer A; Hamzavi I
    Pigment Cell Melanoma Res; 2020 Nov; 33(6):778-787. PubMed ID: 32198977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Innate Immunity to Combat Cutaneous Stress: The Vitiligo Perspective.
    Boniface K; Passeron T; Seneschal J; Tulic MK
    Front Immunol; 2021; 12():613056. PubMed ID: 33936032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitiligo: interplay between oxidative stress and immune system.
    Laddha NC; Dwivedi M; Mansuri MS; Gani AR; Ansarullah M; Ramachandran AV; Dalai S; Begum R
    Exp Dermatol; 2013 Apr; 22(4):245-50. PubMed ID: 23425123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRPM2 mediates mitochondria-dependent apoptosis of melanocytes under oxidative stress.
    Kang P; Zhang W; Chen X; Yi X; Song P; Chang Y; Zhang S; Gao T; Li C; Li S
    Free Radic Biol Med; 2018 Oct; 126():259-268. PubMed ID: 30138713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo.
    Zhou J; An X; Dong J; Wang Y; Zhong H; Duan L; Ling J; Ping F; Shang J
    FASEB J; 2018 Sep; 32(9):4899-4916. PubMed ID: 29613836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone.
    Arowojolu OA; Orlow SJ; Elbuluk N; Manga P
    Exp Dermatol; 2017 Jul; 26(7):637-644. PubMed ID: 28370349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment update for vitiligo based on autoimmune inhibition and melanocyte protection.
    Xie B; Zhu Y; Shen Y; Xu W; Song X
    Expert Opin Ther Targets; 2023 Mar; 27(3):189-206. PubMed ID: 36947026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo: How do oxidative stress-induced autoantigens trigger autoimmunity?
    Xie H; Zhou F; Liu L; Zhu G; Li Q; Li C; Gao T
    J Dermatol Sci; 2016 Jan; 81(1):3-9. PubMed ID: 26387449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalein protects human vitiligo melanocytes from oxidative stress through activation of NF-E2-related factor2 (Nrf2) signaling pathway.
    Ma J; Li S; Zhu L; Guo S; Yi X; Cui T; He Y; Chang Y; Liu B; Li C; Jian Z
    Free Radic Biol Med; 2018 Dec; 129():492-503. PubMed ID: 30342186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIP1-Mediated Necroptosis Facilitates Oxidative Stress‒Induced Melanocyte Death, Offering Insight into Vitiligo.
    Li B; Yi X; Zhuang T; Zhang S; Li S; Yang Y; Cui T; Chen J; Chang Y; Gao T; Li C; Liu L
    J Invest Dermatol; 2021 Dec; 141(12):2921-2931.e6. PubMed ID: 34102211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
    Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
    J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.